Naturland Holding Zrt's yield on cost for the quarter that ended in Jun. 2025 was 3.34.
The historical rank and industry rank for Naturland Holding Zrt's 5-Year Yield-on-Cost % or its related term are showing as below:
BUD:NATURLAND'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 3.34
Current: 3.34
During the past 5 years, Naturland Holding Zrt's highest Yield on Cost was 3.34. The lowest was 0.00. And the median was 0.00.
BUD:NATURLAND's 5-Year Yield-on-Cost % is ranked better than 59.38% of 517
companies
in the Drug Manufacturers industry
Industry Median: 2.34
vs BUD:NATURLAND: 3.34
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Naturland Holding Zrt 5-Year Yield-on-Cost % Related Terms
BUD:NATURLAND vs ZTS, UTHR, VTRS: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Naturland Holding Zrt's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Naturland Holding Zrt 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Naturland Holding Zrt's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Naturland Holding Zrt's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Naturland Holding Zrt (BUD:NATURLAND) has a 5-Year Yield-on-Cost % of 3.34 as of Jul. 03, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Naturland Holding Zrt and its competitors. According to the industry distribution chart, Naturland Holding Zrt ranks #210 out of 517 companies in the Drug Manufacturers industry, placing it in the top 40.6%.
Is Naturland Holding Zrt's 5-Year Yield-on-Cost % too high?
Naturland Holding Zrt's current 5-Year Yield-on-Cost % is 3.34. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.34. Naturland Holding Zrt's value of 3.34 is 42.7% above this industry median. Based on the distribution chart, Naturland Holding Zrt ranks #210 out of 517 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Naturland Holding Zrt has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Naturland Holding Zrt's 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Naturland Holding Zrt ranks #210 out of 517 companies for 5-Year Yield-on-Cost %. This puts Naturland Holding Zrt in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.34. Naturland Holding Zrt's value of 3.34 is 42.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.34, based on 517 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naturland Holding Zrt's current 5-Year Yield-on-Cost % of 3.34 is 42.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Naturland Holding Zrt and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naturland Holding Zrt's current 5-Year Yield-on-Cost % is 3.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturland Holding Zrt stock overvalued right now?
Based on GuruFocus' analysis, Naturland Holding Zrt (BUD:NATURLAND) is currently considered Fairly Valued. The stock's GF Value™ is Ft2,883.57, compared to a current price of Ft2,800.00 — trading 2.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 3.34 and 42.7% above the Drug Manufacturers industry median of 2.34. Naturland Holding Zrt's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Naturland Holding Zrt (BUD:NATURLAND), the current 5-Year Yield-on-Cost % is 3.34 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Naturland Holding Zrt (BUD:NATURLAND) Overvalued in 2026?
Based on GuruFocus' analysis, Naturland Holding Zrt stock appears to be undervalued.
The current stock price of Ft2,800.00 is trading 2.9% below its estimated GF Value™ of Ft2,883.57.
GuruFocus considers Naturland Holding Zrt to be Fairly Valued.
Key valuation signals for BUD:NATURLAND:
5-Year Yield-on-Cost %: 3.34
GF Value™: Ft2,883.57 vs. price of Ft2,800.00 (2.9% below fair value)
Industry Position: 42.7% above the Drug Manufacturers median (#210 of 517)
No single metric tells the full story. See the BUD:NATURLAND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Naturland Holding Zrt thro9ugh its subsidiaries engage in the production of pharmaceutical products. It engages in the development, production, and wholesale of dietary supplements and cosmetics, herbal medicine, teas, and essential oils. The firm offers tablets, suppositories, ointments, and ophthalmic base solutions.
61GF Score
Get the complete analysis for BUD:NATURLAND
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUD:NATURLAND has been successfully added to your 